The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

Objective: To investigate the correlation between the BRAF V600E gene mutation and clinicopathological features and thyroid function after iodine-131 treatment in patients with papillary thyroid cancer (PTC). Methods: A total of 128 PTC patients who underwent iodine-131 treatment after a total thyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Junshang, Wang, Jie, Wang, Hui, Jiang, Xianjie, Liao, Qianjin, Gong, Qian, Mo, Yongzhen, Li, Xiaoling, Li, Guiyuan, Xiong, Wei, Zhao, Jin, Zeng, Zhaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959026/
https://www.ncbi.nlm.nih.gov/pubmed/31949496
http://dx.doi.org/10.7150/jca.33105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959026/
https://www.ncbi.nlm.nih.gov/pubmed/31949496
http://dx.doi.org/10.7150/jca.33105

Ejemplares similares